Abstract
1. Acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BuChE, EC 3.1.1.8) are enzymes that catalyze the hydrolysis of esters of choline.
2. Both AChE and BuChE have been shown to copurify with peptidases.
3. BuChE has also been shown to copurify with other proteins such as transferrin, with which it forms a stable complex. In addition, BuChE is found in association with β-amyloid protein in Alzheimer brain tissues.
4. Since BuChE copurifies with peptidases, we hypothesized that BuChE interacts with these enzymes and that this association had an influence on their catalytic activities. One of the peptidases that copurifies with cholinesterases has specificity similar to trypsin, hence, this enzyme was used as a model to test this hypothesis.
5. Purified BuChE causes a concentration-dependent enhancement of the catalytic activity of trypsin while trypsin does not influence the catalytic activity of BuChE.
6. We suggest that, in addition to its esterase activity, BuChE may assume a regulatory role by interacting with other proteins.
Similar content being viewed by others
REFERENCES
Allemand, P., Bon, S., Massoulié, J., and Vigny, M. (1981). The quaternary structure of chicken acetyl-cholinesterase and butyrylcholinesterase: Effect of collagenase and trypsin. J. Neurochem. 36:860-867.
Balasubramanian, A. S., and Bhanumathy, C. D. (1993). Noncholinergic functions of cholinesterases. FASEB J. 7:1354-1358.
Boopathy, A., and Balasubramanian, A. S. (1987). Peptidase activity exhibited by human serum pseudocholinesterase. Eur. J. Biochem. 162:191-197.
Caroll, R. T., and Emmerling, M. R. (1991). Identification of the trypsin-like activity in commercial preparations of eel acetylcholinesterase. Biochem. Biophys. Res. Commun. 181:358-362.
Checler, F., Grassi, J., Masson, P., and Vincent, J.-P. (1990). Monoclonal antibodies allow precipitation of esterasic but not peptidasic activities associated with butyrylcholinesterase. J. Neurochem. 55:750-755.
Checler, F., Grassi, J., Masson, P., and Vincent, J.-P. (1994). Cholinesterases display genuine aryl acylamidase activity but are totally devoid of intrinsic peptidase activities. J. Neurochem. 62:756-763.
Chong, Y. H., and Suh, Y.-H. (1996). Amyloidogenic processing of Alzheimer's amyloid precursor protein in vitro and its modulation by metal ions and tacrine. Life Sci. 59:545-557.
Chubb, I. W., Hodgson, A. J., and White, G. H. (1980). Acetylcholinesterase hydrolyzes substance P. Neuroscience 5:2065-2072.
Coyle, J. T., Price, D. L., and DeLong, M. R. (1983). Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219:1184-1190.
Darvesh, S., Kumar, R., and Martin, E. (1999). Enzyme kinetics of butyrylcholinesterase and trypsin: Implications in Alzheimer's disease. Can. J. Neurol. Sci. 26:546-547.
Darvesh, S., MacDonald, S. E., Losier, A. M., Martin, E., Hopkins, D. A., and Armour, J. A. (1998). Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity. J. Auton. Nerv. Syst. 71:75-84.
De Serres, M., Sherman, D., Chestnut, W., Merrill, B. M., Viveros, O. H., and Diliberto, E. J., Jr. (1993). Proteolysis at the secretase and amyloidogenic cleavage sites of the beta-amyloid precursor protein by acetylcholineterase and butyrylcholinesterase using model peptide substrates. Cell Mol. Neurobiol. 13:279-287.
Dixon, M., and Webb, E. C. (1979). Enzymes, 3rd edn., Academic Press, New York, pp. 389-391.
Ellman, G. L., Courtney, K. D., Andres, V., Jr., and Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88-95.
Friede, R. L. (1965). Enzyme histochemical studies of senile plaques. J. Neuropathol. Exp. Neurol. 24:477-491.
Gatley, S. J. (1991). Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase. biochem. Pharmacol. 41:1249-1254.
Geula, C., Greenberg, D., and Mesulam, M.-M. (1994). Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid. Brain Res. 644:327-330.
Geula, C., and Mesulam, M.-M. (1989). Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res. 498:185-189.
Geula, C., and Mesulam, M.-M. (1995). Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2:23-28.
Giacobini, E., Griffini, P. L., Maggi, T., Mascellani, G., and Mandelli, R. (1996). Butyrylcholinesterase: Is it important for cortical acetylcholine regulation? Neurosci. Abs. 22:203.
Gomez-Ramos, P., Bouras, C., and Moran, M. A. (1994). Ultrastructural localization of butyryl-cholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients. Brain Res. 640:17-24.
Grunwald, J., Marcus, D., Papier, Y., Raveh, L., Pittel, Z., and Ashani, Y. (1997). Large-scale purification and long-term stability of human butyrylcholinesterase: A potential bioscavenger drug. J. Biochem. Biophys. Methods 34:123-135.
Guillozet, A. L., Smiley, J. F., Mash, D. C., and Mesulam, M.-M. (1997). Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 42:909-918.
Koshikawa, N., Hasegawa, S., Nagashima, Y., Mitsuhashi, K., Tsubota, Y., Miyata, S., Miyagi, Y., Yasumitsu, H., and Miyazaki, K. (1998). Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am. J. Pathol. 153:937-944.
Kruger-Thiemer, E. (1969). Generalized kinetics of reversible inhibition and activation. Eur. J. Pharmacol. 6:357-360.
Layer, P. G. (1995). Non-classical roles of cholinesterases in the embryonic brain and possible links to Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9:29-36.
Li, B., Stribley, J. A., Ticu, A., Xie, W., Schopfer, L. M., Hammond, P., Brimijoin, S., Hinrichs, S. H., and Lockridge, O. (2000). Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75:1320-1331.
Lockridge, O. (1982). Substance P hydrolysis by human serum cholinesterase. J. Neurochem. 36:106-110.
Lockridge, O., and La Du, B. N. (1982). Loss of the interchain disulfide peptide and dissociation of the tetramer following limited proteolysis of native human serum cholinesterase. J. Biol. Chem. 257:12012-12018.
Lockridge, O., Mottershaw-Jackson, N., Eckerson, H., and La Du, B. N. (1980). Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase. J. Pharmacol. Exp. Ther. 215:1-8.
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., and LeWitt, P. (1995). Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J. Neurochem. 65:710-724.
Masson, P. (1989). A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate. Biochim. Biophys. Acta 998:258-266.
Masson, P., Froment, M. T., Fortier, P. L., Visicchio, J. E., Bartels, C. F., and Lockridge, O. (1998). Butyrylcholinesterase-catalyzed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters. Biochim. Biophys. Acta 1387:41-52.
Meckelein, B., Marshall, D. C. L., Conn, K.-J., Pietopaolo, M., Van Nostrand, W., and Abraham, C. (1998). Identification of a novel serine protease-like molecule in human brain. Brain Res. Mol. Brain Res. 55:181-197.
Mescher, A. L., and Munaim, S. I. (1988). Transferrin and the growth-promoting effect of nerves. Int. Rev. Cytol. 110:1-26.
Mesulam, M.-M., and Geula, C. (1994). Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann. Neurol. 36:722-727.
Minn, A., Schubert, M., Neiss, W. F., and Muller-Hill, B. (1998). Enhanced GFAP expression in astrocytes of transgenic mice expressing the human brain-specific trypsinogen IV. Glia 22:338-347.
Morrison, J. F., and Ebner, K. E. (1971). Studies on galactosyltransferase: Kinetic effects of α-lactalbumin with N-acetylglucosamine and glucose as galactosyl group acceptors. J. Biol. Chem. 246:3992-3998.
Norel, X., Angrisani, M., Labat, C., Gorenne, I., Dulmet, E., Rossi, F., and Brink, C. (1993). Degradation of acetylcholine in human airways: Role of butyrylcholinesterase. Br. J. Pharmacol. 109:914-919.
Nunan, J., and Small, D. H. (2000). Regulation of APP cleavage by alpha-, beta-and gamma-secretases. FEBS Lett. 483:6-10.
Ogawa, K., Yamada, T., Tsujioka, Y., Taguchi, J., Takahashi, M., Tsuboi, Y., Fujino, Y., Nakajima, M., Yamamoto, T., Akatsu, H., Mitsui, S., and Yamaguchi, N. (2000). Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease. Psychiatry Clin. Neurosci. 54:419-426.
Op den Velde, W., and Stam, F. C. (1976). Some cerebral proteins and enzyme systems in Alzheimer's presenile and senile dementia. J. Am. Geriatr. Soc. 24:12-16.
Perry, E. K., Perry, R. H., Blessed, G., and Tomlinson, B. E. (1978). Changes in brain cholinesterases in senile dementia of the Alzheimer type. Neuropathol. Appl. Neurobiol. 4:273-277.
Rao, R. V., and Balasubramanian, A. S. (1990). Localization of the peptidase activity of human serum butyrylcholinesterase in a approximately 50-kDa fragment obtained by limited alpha-chymotrypsin digestion. Eur. J. Biochem. 188:637-643.
Rao, R. V., and Balasubramanian, A. S. (1993). The peptidase activity of human serum butyrylcholinesterase: Studies using monoclonal antibodies and characterization of the peptidase. J. Protein Chem. 12:103-110.
Robitzki, A., Doll, F., Richter-Landsberg, C., and Layer, P.G. (2000). Regulation of the rat oligodendroglia cell line OLN-93 by antisense transfection of butyrylcholinesterase. Glia 31:195-205.
Silver, A. (1974). The Biology of Cholinesterases, Elsevier, Amsterdam.
Small, D. H. (1988). Serum acetylcholinesterase possesses trypsin-like and carboxypeptidase B-like activity. Neurosci. Lett. 95:307-312.
Small, D. H. (1990). Non-cholinergic actions of acetylcholinesterases: Proteases regulating cell growth and development? Trends Biochem. Sci. 15:213-216.
Small, D. H., Ismael, Z., and Chubb, I. W. (1987). Acetylcholinesterase exhibits trypsin-like and metalloexopeptidase-like activity in cleaving a model peptide. Neuroscience 21:991-995.
Small, D. H., Michaelson, S., and Sberna, G. (1996). Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28:453-483.
Small, D. H., Moir, R. D., Fuller, S. J., Michaelson, S., Bush, A. I., Li, Q.-X., Milward, E., Hilbich, E., Weidenmann, A., Beyreuther, K., and Masters, C. L. (1991). A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease. Biochemistry 30:10795-10799.
Tomita, S., Kirino, Y., and Suzuki, T. (1998). A basic amino acid in the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein (APP) is essential for cleavage of APP at the alpha-site. J. Biol. Chem. 273:19304-19310.
Vigny, M., Gisiger, V., and Massoulié, J. (1978). “Nonspecific” cholinesterase and acetylcholinesterase in rat tissues: Molecular forms, structural and catalytic properties, and significance of the two enzyme systems. Proc. Natl. Acad. Sci. USA 75:2588-2592.
Weitnauer, E., Ebert, C., Hucho, F., Robitzki, A., Weise, C., and Layer, P. G. (1999). Butyrylcholinesterase is complexed with transferrin in chicken serum. J. Protein Chem. 18:205-214.
Wright, C. I., Geula, C., and Mesulam, M.-M. (1993). Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles, and patterns of selective vulnerability. Ann. Neurol. 34:373-384.
Yoshida, S., Taniguchi, M., Suemoto, T., Oka, T., He, X., and Shiosaka, S. (1998). cDNA cloning and expression of a novel serine protease, TLSP. Biochim. Biophys. Acta 1399:225-228.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Darvesh, S., Kumar, R., Roberts, S. et al. Butyrylcholinesterase-Mediated Enhancement of the Enzymatic Activity of Trypsin. Cell Mol Neurobiol 21, 285–296 (2001). https://doi.org/10.1023/A:1010947205224
Issue Date:
DOI: https://doi.org/10.1023/A:1010947205224